SCHEMBL2614945

SCHEMBL2614945

Cc1cnc(-c2ccc(Cl)cc2)cn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.47
RAB9A P51151 6/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
KDM1A O60341 1/20 0.45
MAOB P27338 1/20 0.45
KDM4E B2RXH2 5/20 0.43
ALDH1A1 P00352 3/20 0.43
METAP2 P50579 1/20 0.42
NOTUM Q6P988 1/20 0.42
KMT2A Q03164 2/20 0.39
P2RX7 Q99572 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ABL1 P00519 1/20 0.38
GAA P10253 2/20 0.38
MEN1 O00255 1/20 0.38
RUNX1 Q01196 1/20 0.38
CBFB Q13951 1/20 0.38
TP53 P04637 2/20 0.38
HPGD P15428 2/20 0.38
USP2 O75604 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15599290 0.89 ABL1 (0.43) NPC1RAB9ASMN1; SMN2KDM1AALDH1A1
SCHEMBL10000240 0.83 KDM1A (0.47) NPC1RAB9ASMN1; SMN2KDM1AKDM4E
SCHEMBL17051511 0.81 KDM1A (0.46) NPC1RAB9ASMN1; SMN2KDM1AKDM4E
SCHEMBL17051555 0.81 KDM1A (0.46) NPC1RAB9ASMN1; SMN2KDM1AKDM4E
SCHEMBL17051527 0.79 HPGDS (0.43) NPC1RAB9AKDM1AKMT2AABL1
SCHEMBL30497728 0.79 KEAP1 (0.42) NPC1RAB9ASMN1; SMN2KDM1AKDM4E
SCHEMBL10165350 0.79 MAPK1 (0.46) NPC1RAB9ASMN1; SMN2ALDH1A1ABL1
SCHEMBL17055548 0.79 MEN1 (0.49) NPC1RAB9ASMN1; SMN2KMT2AMEN1
SCHEMBL11679569 0.78 NPC1 (0.50) NPC1RAB9ASMN1; SMN2KDM1AMAOB
SCHEMBL15784437 0.78 HPGDS (0.46) NPC1RAB9AKMT2AP2RX7ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8785445-B2 7-phenoxychroman carboxylic acid derivatives ARRAY BIOPHARMA INC. (US) 2014-07-22 US disclosed
US-20120101103-A1 7-PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2012-04-26 US disclosed
WO-2010075200-A1 7-PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2010-07-01 WO disclosed
EP-0194686-A1 Pyrazine derivatives TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION (JP) 1986-09-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120101103-A1 7-PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES PTGDR2, PTGDR, HRH2 NPC1 4029/4885RAB9A 1293/4885SMN1; SMN2 4615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.